HK Stock MarketDetailed Quotes

00300 MIDEA GROUP

Watchlist

72.950
-3.650-4.77%

Market Closed Apr 3 16:08 CST

558.82BMarket Cap13.43P/E (TTM)

MIDEA GROUP Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Turnover

9.47%409.08B

--318.97B

10.28%218.12B

8.10%373.71B

7.69%197.8B

0.68%345.71B

--183.66B

20.18%343.36B

--285.71B

Special items of operating revenue

----

--1.38B

----

Operating income

9.47%409.08B

320.35B

10.28%218.12B

8.10%373.71B

7.69%197.8B

0.68%345.71B

183.66B

20.18%343.36B

285.71B

Cost of sales

-8.53%-301.98B

----

-7.60%-159.63B

-6.07%-278.25B

-4.98%-148.35B

1.55%-262.32B

---141.32B

-21.86%-266.45B

---218.65B

Operating expenses

-8.53%-301.98B

-233.63B

-7.60%-159.63B

-6.07%-278.25B

-4.98%-148.35B

1.55%-262.32B

-141.32B

-21.86%-266.45B

-218.65B

Gross profit

12.19%107.1B

86.72B

18.30%58.49B

14.48%95.46B

16.76%49.44B

8.42%83.39B

42.35B

14.70%76.91B

67.06B

Selling expenses

-21.28%-38.75B

---31.16B

-25.23%-21.46B

-11.27%-31.95B

-16.57%-17.13B

-0.24%-28.72B

---14.7B

-21.58%-28.65B

---23.56B

Administrative expenses

-10.22%-15.4B

---10.36B

-17.96%-6.96B

-16.23%-13.98B

-13.95%-5.9B

-11.93%-12.02B

---5.18B

-10.52%-10.74B

---9.72B

Research and development expenses

-11.29%-16.23B

---11.4B

-15.85%-7.66B

-15.15%-14.59B

-12.65%-6.61B

-5.43%-12.67B

---5.87B

-17.85%-12.01B

---10.19B

Profit from asset sales

----

--258.26M

----

Revaluation surplus

----

--328.54M

----

-Changes in the fair value of other assets

----

--328.54M

----

Impairment and provision

112.20%28.68M

---486.22M

83.94%-35.21M

56.33%-235M

-1.25%-219.21M

-39.95%-538.11M

---216.51M

-28.27%-384.5M

---299.76M

-Other impairment is provision

112.20%28.68M

---486.22M

83.94%-35.21M

56.33%-235M

-1.25%-219.21M

-39.95%-538.11M

---216.51M

-28.27%-384.5M

---299.76M

Operating interest expense

----

---1.82M

----

Special items of operating profit

40.44%10.08B

--2.93B

-26.16%2.82B

19.11%7.17B

43.54%3.81B

-32.73%6.02B

--2.66B

-0.29%8.95B

--8.98B

Operating profit

11.77%46.82B

35.19B

7.71%25.19B

18.10%41.89B

22.85%23.39B

4.08%35.47B

19.04B

5.63%34.08B

32.26B

Financing income

-12.94%944.79M

----

47.77%697.28M

36.82%1.09B

63.08%471.86M

97.55%793.18M

--289.34M

8.04%401.5M

--371.63M

Financing cost

43.18%-1.92B

--2.98B

58.72%-866.07M

-77.29%-3.37B

-178.62%-2.1B

-46.39%-1.9B

---752.93M

5.63%-1.3B

---1.38B

Share of profits of associates

24.43%847.1M

----

23.93%431.94M

11.92%680.76M

32.52%348.55M

8.49%608.28M

--263.01M

39.29%560.68M

--402.53M

Special items of earning before tax

----

---6.18M

----

Adjustment items of earning before tax

----

--224.45M

----

Earning before tax

15.92%46.69B

38.4B

15.12%25.45B

15.22%40.28B

17.38%22.11B

3.62%34.96B

18.83B

6.58%33.74B

31.66B

Tax

-21.44%-7.93B

---6.25B

-20.45%-4.31B

-26.93%-6.53B

-32.01%-3.58B

-9.33%-5.15B

---2.71B

-13.28%-4.71B

---4.16B

After-tax profit from continuing operations

14.85%38.76B

32.15B

14.10%21.14B

13.20%33.75B

14.92%18.53B

2.69%29.81B

16.12B

5.56%29.03B

27.5B

Earning after tax

14.85%38.76B

32.15B

14.10%21.14B

13.20%33.75B

14.92%18.53B

2.69%29.81B

16.12B

5.56%29.03B

27.5B

Minority profit

765.47%219.98M

--451.87M

13.66%337.08M

-90.18%25.42M

130.08%296.56M

-41.77%258.78M

--128.89M

59.44%444.45M

--278.76M

Profit attributable to shareholders

14.29%38.54B

31.7B

14.10%20.8B

14.10%33.72B

13.99%18.23B

3.38%29.55B

15.99B

5.01%28.59B

27.22B

Basic earnings per share

10.34%5.44

4.58

13.11%3.02

13.59%4.93

14.10%2.67

4.08%4.34

2.34

6.11%4.17

3.93

Diluted earnings per share

10.16%5.42

4.57

13.16%3.01

13.63%4.92

13.68%2.66

4.59%4.33

2.34

6.15%4.14

3.9

Currency Unit

CNY

Accounting Standards

IAS

CAS (2007)

IAS

Audit Opinions

Unqualified Opinion

Auditor

PricewaterhouseCoopers

	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Turnover	9.47%409.08B	--318.97B	10.28%218.12B	8.10%373.71B	7.69%197.8B	0.68%345.71B	--183.66B	20.18%343.36B	--285.71B
Special items of operating revenue	----	--1.38B	----	----	----	----	----	----	----
Operating income	9.47%409.08B	320.35B	10.28%218.12B	8.10%373.71B	7.69%197.8B	0.68%345.71B	183.66B	20.18%343.36B	285.71B
Cost of sales	-8.53%-301.98B	----	-7.60%-159.63B	-6.07%-278.25B	-4.98%-148.35B	1.55%-262.32B	---141.32B	-21.86%-266.45B	---218.65B
Operating expenses	-8.53%-301.98B	-233.63B	-7.60%-159.63B	-6.07%-278.25B	-4.98%-148.35B	1.55%-262.32B	-141.32B	-21.86%-266.45B	-218.65B
Gross profit	12.19%107.1B	86.72B	18.30%58.49B	14.48%95.46B	16.76%49.44B	8.42%83.39B	42.35B	14.70%76.91B	67.06B
Selling expenses	-21.28%-38.75B	---31.16B	-25.23%-21.46B	-11.27%-31.95B	-16.57%-17.13B	-0.24%-28.72B	---14.7B	-21.58%-28.65B	---23.56B
Administrative expenses	-10.22%-15.4B	---10.36B	-17.96%-6.96B	-16.23%-13.98B	-13.95%-5.9B	-11.93%-12.02B	---5.18B	-10.52%-10.74B	---9.72B
Research and development expenses	-11.29%-16.23B	---11.4B	-15.85%-7.66B	-15.15%-14.59B	-12.65%-6.61B	-5.43%-12.67B	---5.87B	-17.85%-12.01B	---10.19B
Profit from asset sales	----	--258.26M	----	----	----	----	----	----	----
Revaluation surplus	----	--328.54M	----	----	----	----	----	----	----
-Changes in the fair value of other assets	----	--328.54M	----	----	----	----	----	----	----
Impairment and provision	112.20%28.68M	---486.22M	83.94%-35.21M	56.33%-235M	-1.25%-219.21M	-39.95%-538.11M	---216.51M	-28.27%-384.5M	---299.76M
-Other impairment is provision	112.20%28.68M	---486.22M	83.94%-35.21M	56.33%-235M	-1.25%-219.21M	-39.95%-538.11M	---216.51M	-28.27%-384.5M	---299.76M
Operating interest expense	----	---1.82M	----	----	----	----	----	----	----
Special items of operating profit	40.44%10.08B	--2.93B	-26.16%2.82B	19.11%7.17B	43.54%3.81B	-32.73%6.02B	--2.66B	-0.29%8.95B	--8.98B
Operating profit	11.77%46.82B	35.19B	7.71%25.19B	18.10%41.89B	22.85%23.39B	4.08%35.47B	19.04B	5.63%34.08B	32.26B
Financing income	-12.94%944.79M	----	47.77%697.28M	36.82%1.09B	63.08%471.86M	97.55%793.18M	--289.34M	8.04%401.5M	--371.63M
Financing cost	43.18%-1.92B	--2.98B	58.72%-866.07M	-77.29%-3.37B	-178.62%-2.1B	-46.39%-1.9B	---752.93M	5.63%-1.3B	---1.38B
Share of profits of associates	24.43%847.1M	----	23.93%431.94M	11.92%680.76M	32.52%348.55M	8.49%608.28M	--263.01M	39.29%560.68M	--402.53M
Special items of earning before tax	----	----	----	----	----	---6.18M	----	----	----
Adjustment items of earning before tax	----	--224.45M	----	----	----	----	----	----	----
Earning before tax	15.92%46.69B	38.4B	15.12%25.45B	15.22%40.28B	17.38%22.11B	3.62%34.96B	18.83B	6.58%33.74B	31.66B
Tax	-21.44%-7.93B	---6.25B	-20.45%-4.31B	-26.93%-6.53B	-32.01%-3.58B	-9.33%-5.15B	---2.71B	-13.28%-4.71B	---4.16B
After-tax profit from continuing operations	14.85%38.76B	32.15B	14.10%21.14B	13.20%33.75B	14.92%18.53B	2.69%29.81B	16.12B	5.56%29.03B	27.5B
Earning after tax	14.85%38.76B	32.15B	14.10%21.14B	13.20%33.75B	14.92%18.53B	2.69%29.81B	16.12B	5.56%29.03B	27.5B
Minority profit	765.47%219.98M	--451.87M	13.66%337.08M	-90.18%25.42M	130.08%296.56M	-41.77%258.78M	--128.89M	59.44%444.45M	--278.76M
Profit attributable to shareholders	14.29%38.54B	31.7B	14.10%20.8B	14.10%33.72B	13.99%18.23B	3.38%29.55B	15.99B	5.01%28.59B	27.22B
Basic earnings per share	10.34%5.44	4.58	13.11%3.02	13.59%4.93	14.10%2.67	4.08%4.34	2.34	6.11%4.17	3.93
Diluted earnings per share	10.16%5.42	4.57	13.16%3.01	13.63%4.92	13.68%2.66	4.59%4.33	2.34	6.15%4.14	3.9
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	CAS (2007)	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	PricewaterhouseCoopers	--	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.